# Ever Fortune AI signs long-term deal with Temasek kidney device firm

Ever Fortune AI (Chang Gung Intelligent) has signed a 15-year technology transfer and co-development agreement with a Temasek-owned kidney disease medical device company, expected to generate $37-38 million in revenue.

- Type: Contract
- Announced: 2023-01-17
- Where: TWN
- Value: $38.0M
- Status: completed
- Products: kidney disease care platform, wearable medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ever Fortune AI](https://endata.com/companies/67914.md)
- [Temasek Holdings](https://endata.com/companies/18585.md) (partner)

## Sources

- [news.cnyes.com](https://news.cnyes.com/news/id/5065422), 2023-01-17: "與淡馬錫投控旗下腎臟病醫材公司簽定長約，初估營收貢獻超過 10 億元"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.